
An artificial intelligence health hub is set to open at Campus Biotech
17 February 2025

The University Hospitals of Geneva (HUG), the Department of Health and Mobilities (DSM) of the Canton of Geneva, and the Wyss Center are joining forces to establish Switzerland’s first artificial intelligence health hub at Campus Biotech, set to open in the second half of 2025.
The University Hospitals of Geneva (HUG), in collaboration with the Department of Health and Mobilities (DSM) of Geneva and the Wyss Center for Bio and Neuro Engineering, have announced the creation of Switzerland’s first AI-driven health hub at Campus Biotech. This initiative aims to enhance the treatment and prevention of neurological and psychiatric disorders by integrating artificial intelligence into healthcare.
Spanning 1,000 square meters at the entrance of Campus Biotech, the hub will provide an advanced multidisciplinary environment where medical professionals, AI researchers, and industry leaders collaborate. HUG will oversee its management, ensuring alignment with hospital expertise and technological innovation. Robert Mardini, Director General of HUG, emphasized its importance, stating that the hub will bring together AI-driven hospital and research capabilities, fostering synergies between cutting-edge technology and patient care.
The hub will focus on four key areas: patient care, translational research, AI integration in healthcare, and education. In terms of patient care, it will support neuromodulation treatments for epilepsy, strokes, depression, and sleep disorders, with AI-assisted diagnostics and tailored treatments improving care quality. On the research and innovation front, the Wyss Center will lead AI-guided neuromodulation research, fostering start-ups such as dEEGtal, which develops AI-based epilepsy diagnostic tools.
AI integration and Geneva’s vision for healthcare innovation
HUG will implement AI technologies in healthcare, improving medical administration, optimizing patient flow management, and advancing digital health innovations. Additionally, the DSM will oversee education and dialogue, organizing training programs, town hall discussions, and global health dialogues. Geneva’s international reputation as a hub for healthcare and innovation will allow the AI health hub to engage with a broader network of stakeholders.
The project aligns with Geneva’s 2023-2028 legislative agenda to stimulate innovation through AI clusters. Co-funded by HUG, the State of Geneva, and the Wyss Center, each entity will invest CHF 900,000 over three years. The hub is expected to be fully operational by late 2025 and transition into an exclusive HUG clinical and research facility by 2028. With this initiative, Geneva cements its leadership in AI-driven healthcare, offering new solutions for complex neurological and psychiatric conditions.